GSA Capital Partners’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.09M | Sell |
|
|||||
2025
Q1 | $1.53M | Buy |
|
|||||
2024
Q4 | $1.41M | Buy |
|
|||||
2024
Q3 | $665K | Buy |
|
|||||
2024
Q1 | – | Sell |
|
|||||
2023
Q4 | $403K | Buy |
|
|||||
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $259K | Sell |
|
|||||
2022
Q3 | $606K | Buy |
|
|||||
2022
Q2 | $313K | Buy |
|
|||||
2021
Q4 | – | Sell |
|
|||||
2021
Q3 | $1.35M | Buy |
|
|||||
2021
Q2 | $211K | Buy |
|
|||||
2020
Q2 | – | Sell |
|
|||||
2020
Q1 | $206K | Sell |
|
|||||
2019
Q4 | $375K | Sell |
|
|||||
2019
Q3 | $918K | Buy |
|
|||||
2019
Q2 | $514K | Sell |
|
|||||
2019
Q1 | $1.82M | Buy |
|
|||||
2018
Q4 | $1.01M | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $270K | Sell |
|
|||||
2017
Q1 | $442K | Sell |
|
|||||
2016
Q4 | $911K | Sell |
|
|||||
2016
Q3 | $2.29M | Sell |
|
|||||
2016
Q2 | $5.6M | Sell |
|
|||||
2016
Q1 | $7.55M | Buy |
|
|||||
2015
Q4 | $4.55M | Sell |
|
|||||
2015
Q3 | $8.29M | Buy |
|
|||||
2015
Q2 | $4.67M | Buy |
|
|||||
2015
Q1 | $3.15M | Buy |
|
|||||
2014
Q4 | $2.21M | Buy |
|
|||||
2014
Q3 | – | Sell |
|
|||||
2014
Q2 | $15.2M | Buy |
|
|||||
2014
Q1 | $1.18M | Sell |
|
|||||
2013
Q4 | $4.47M | Buy |
|
|||||
2013
Q3 | – | Sell |
|
|||||
2013
Q2 | $4.69M | Buy |
|